These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

421 related articles for article (PubMed ID: 32720578)

  • 1. Identification of some novel oxazine substituted 9-anilinoacridines as SARS-CoV-2 inhibitors for COVID-19 by molecular docking, free energy calculation and molecular dynamics studies.
    Rajagopal K; Varakumar P; Aparna B; Byran G; Jupudi S
    J Biomol Struct Dyn; 2021 Sep; 39(15):5551-5562. PubMed ID: 32720578
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activity of phytochemical constituents of
    Rajagopal K; Varakumar P; Baliwada A; Byran G
    Futur J Pharm Sci; 2020; 6(1):104. PubMed ID: 33215042
    [TBL] [Abstract][Full Text] [Related]  

  • 3.
    Maurya AK; Mishra N
    J Biomol Struct Dyn; 2021 Nov; 39(18):7306-7321. PubMed ID: 32835632
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In-silico Design, ADMET Screening, MM-GBSA Binding Free Energy of Some Novel Isoxazole Substituted 9-Anilinoacridines as HER2 Inhibitors Targeting Breast Cancer.
    Kalirajan R; Pandiselvi A; Gowramma B; Balachandran P
    Curr Drug Res Rev; 2019; 11(2):118-128. PubMed ID: 31513003
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Virtual screening, ADMET prediction and dynamics simulation of potential compounds targeting the main protease of SARS-CoV-2.
    Yadav R; Imran M; Dhamija P; Chaurasia DK; Handu S
    J Biomol Struct Dyn; 2021 Oct; 39(17):6617-6632. PubMed ID: 32715956
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibitory potential of repurposed drugs against the SARS-CoV-2 main protease: a computational-aided approach.
    Fadaka AO; Aruleba RT; Sibuyi NRS; Klein A; Madiehe AM; Meyer M
    J Biomol Struct Dyn; 2022 May; 40(8):3416-3427. PubMed ID: 33200673
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pyrazole Substituted 9-Anilinoacridines as HER2 Inhibitors Targeting Breast Cancer - An in-silico approach.
    Rajagopal K; Sri VB; Byran G; Gomathi S
    Curr Drug Res Rev; 2022; 14(1):61-72. PubMed ID: 34139975
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phytoconstituents of Citrus limon (Lemon) as Potential Inhibitors Against Multi Targets of SARS-CoV-2 by Use of Molecular Modelling and In Vitro Determination Approaches.
    Raman K; Kalirajan R; Islam F; Jupudi S; Selvaraj D; Swaminathan G; Singh LP; Rana R; Akash S; Islam MR; Nainu F; Emran TB; Dawoud TM; Bourhia M; Dauelbait M; Barua R
    ChemistryOpen; 2024 Oct; 13(10):e202300198. PubMed ID: 39031747
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting SARS-CoV-2 main protease: structure based virtual screening, in silico ADMET studies and molecular dynamics simulation for identification of potential inhibitors.
    Uniyal A; Mahapatra MK; Tiwari V; Sandhir R; Kumar R
    J Biomol Struct Dyn; 2022 May; 40(8):3609-3625. PubMed ID: 33226303
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In-silico screening and molecular dynamics simulation of quinazolinone derivatives as PARP1 and STAT3 dual inhibitors: a novel DML approaches.
    Dilipkumar S; Karthik V; Dk S; Gowramma B; Lakshmanan K
    J Biomol Struct Dyn; 2024; 42(20):10824-10834. PubMed ID: 37735921
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Virtual screening of natural products inspired in-house library to discover potential lead molecules against the SARS-CoV-2 main protease.
    Garg A; Goel N; Abhinav N; Varma T; Achari A; Bhattacharjee P; Kamal IM; Chakrabarti S; Ravichandiran V; Reddy AM; Gupta S; Jaisankar P
    J Biomol Struct Dyn; 2023 Mar; 41(5):2033-2045. PubMed ID: 35043750
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Finding potent inhibitors against SARS-CoV-2 main protease through virtual screening, ADMET, and molecular dynamics simulation studies.
    Roy R; Sk MF; Jonniya NA; Poddar S; Kar P
    J Biomol Struct Dyn; 2022 Sep; 40(14):6556-6568. PubMed ID: 33682642
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In silico analysis and identification of antiviral coumarin derivatives against 3-chymotrypsin-like main protease of the novel coronavirus SARS-CoV-2.
    Abdizadeh R; Hadizadeh F; Abdizadeh T
    Mol Divers; 2022 Apr; 26(2):1053-1076. PubMed ID: 34213728
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacophore based virtual screening, molecular docking, molecular dynamics and MM-GBSA approach for identification of prospective SARS-CoV-2 inhibitor from natural product databases.
    Kumar BK; Faheem ; Sekhar KVGC; Ojha R; Prajapati VK; Pai A; Murugesan S
    J Biomol Struct Dyn; 2022 Feb; 40(3):1363-1386. PubMed ID: 32981461
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of potential SARS-CoV-2 M
    Sobhia ME; Ghosh K; Sivangula S; Kumar S; Singh H
    J Biomol Struct Dyn; 2022 Jul; 40(11):5079-5089. PubMed ID: 33413032
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In-silico Design, ADMET Screening, Prime MM-GBSA Binding Free Energy Calculation and MD Simulation of Some Novel Phenothiazines as 5HT6R Antagonists Targeting Alzheimer's Disease.
    V P; A M; N R
    Curr Comput Aided Drug Des; 2024 Jan; ():. PubMed ID: 38204222
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular docking and simulation studies of natural compounds of
    Mitra D; Verma D; Mahakur B; Kamboj A; Srivastava R; Gupta S; Pandey A; Arora B; Pant K; Panneerselvam P; Ghosh A; Barik DP; Mohapatra PKD
    J Biomol Struct Dyn; 2022 Aug; 40(12):5665-5686. PubMed ID: 33459176
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of 1,2,3-triazole-phthalimide derivatives as potential drugs against COVID-19: a virtual screening, docking and molecular dynamic study.
    Holanda VN; Lima EMA; Silva WVD; Maia RT; Medeiros RL; Ghosh A; Lima VLM; Figueiredo RCBQ
    J Biomol Struct Dyn; 2022 Aug; 40(12):5462-5480. PubMed ID: 33459182
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of phytocompounds from Houttuynia cordata Thunb. as potential inhibitors for SARS-CoV-2 replication proteins through GC-MS/LC-MS characterization, molecular docking and molecular dynamics simulation.
    Das SK; Mahanta S; Tanti B; Tag H; Hui PK
    Mol Divers; 2022 Feb; 26(1):365-388. PubMed ID: 33961167
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 25 (S)-Hydroxycholesterol acts as a possible dual enzymatic inhibitor of SARS-CoV-2 M
    Alzahrani FA; Alkarim SA; Hawsawi YM; Abdulaal WH; Albiheyri R; Kurdi B; Alguridi H; El-Magd MA
    J Biomol Struct Dyn; 2023 Jul; 41(10):4744-4755. PubMed ID: 35510619
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.